InvestorsHub Logo
Followers 743
Posts 61882
Boards Moderated 10
Alias Born 10/05/2009

Re: Vision and Value post# 960

Wednesday, 03/08/2023 1:33:12 PM

Wednesday, March 08, 2023 1:33:12 PM

Post# of 1262
IMO, $BIXT will be the next Moderna, not vaccines like Moderna, but a whole new class of Antivials, starting with Covid19.

And it is no toxic, no negative side effects. Shocker

Repeat covid19 infections, Long Haul Covid caused by Covid19 spikes make by the immune system over reacting to the mRNA vaccines, or frequent re-exposure to others with the highly contagious Omicron strains, have huge potential as well for the $BIXT product.

There is another I think, with a solid opp for Immune system caused Long Haul Covid19 caused by Micro blood clots (recent research) that just US FDA approval for end points to change of the nearly finished Covid19 trial, that is following a path I suggested last summer, of adding Long haul Covid to the trail data.
It is Rvvtf

I own shares in both, and will be accumulating more shares of both this year.
I do not see them as competitors. Long story.....

These are the only two I think have a real shot at game changer results, and mega Billion dollar buy outs.
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BIXT News